Viewing Study NCT01184092


Ignite Creation Date: 2025-12-24 @ 3:56 PM
Ignite Modification Date: 2026-01-01 @ 10:15 AM
Study NCT ID: NCT01184092
Status: COMPLETED
Last Update Posted: 2010-10-14
First Post: 2010-08-16
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study To Compare The Amount Of Tasocitinib (CP-690,550) That Is Absorbed Into The Blood Of Healthy Subjects Following Oral Administration Of Three Different Tablet Versions Of Tasocitinib (CP-690,550)
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module